| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |